Outcomes and Sex Differences in Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy-Insights from a

Tetsuo Yamaguchi1, Mitsuyoshi Takahara2, Shun Kohsaka3

  • 1Department of Cardiovascular Center, Toranomon Hospital, Tokyo, Japan.

Insights

Alcohol septal ablation (ASA) effectively reduces left ventricular outflow tract gradients in obstructive hypertrophic cardiomyopathy (HOCM) patients in Japan. While safe, female sex is linked to higher risks of heart block requiring pacemakers.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • Obstructive hypertrophic cardiomyopathy (HOCM) significantly impacts patient quality of life.
  • Alcohol septal ablation (ASA) is an established treatment for symptomatic HOCM.
  • Limited data exist on current ASA practices and outcomes specifically within Japan.

Purpose of the Study:

  • To evaluate the current practice and in-hospital outcomes of ASA in Japan.
  • To identify predictors of procedural success and complications following ASA.
  • To assess the safety and efficacy of ASA for HOCM patients in a Japanese nationwide registry.

Main Methods:

  • Analysis of data from 634 patients who underwent ASA between January 2019 and December 2022.
  • Data extracted from the nationwide prospective J-SHD registry.
  • Multivariate logistic regression used to identify predictors of success and complications.

Main Results:

  • Successful alcohol injection in 99.6% of cases, significantly reducing LVOT gradient (72.0 to 20.9 mmHg).
  • Low in-hospital mortality (0.16%) and low rates of ventricular arrhythmia (0.63%).
  • High-grade heart block requiring permanent pacemaker implantation occurred in 7.9% of patients; female sex predicted this complication.

Conclusions:

  • Alcohol septal ablation is a safe and effective therapy for symptomatic obstructive hypertrophic cardiomyopathy in Japan.
  • Higher pre-procedural LVOT gradient predicts successful gradient reduction.
  • Female sex is an independent predictor of high-grade heart block requiring pacemaker implantation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
699
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357